145 related articles for article (PubMed ID: 22012915)
21. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
23. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
24. Architecture and membrane interactions of the EGF receptor.
Arkhipov A; Shan Y; Das R; Endres NF; Eastwood MP; Wemmer DE; Kuriyan J; Shaw DE
Cell; 2013 Jan; 152(3):557-69. PubMed ID: 23374350
[TBL] [Abstract][Full Text] [Related]
25. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.
Kaushansky A; Gordus A; Budnik BA; Lane WS; Rush J; MacBeath G
Chem Biol; 2008 Aug; 15(8):808-17. PubMed ID: 18721752
[TBL] [Abstract][Full Text] [Related]
26. Geometrical Conversion of the EGFR Extracellular Domain by Adiabatic Mapping Combining Normal Mode Analysis of the Elastic Network Model and Energy Optimization.
Nojima H; Kiyota Y; Terashi G; Takeda-Shitaka M; Matsubara H
Chem Pharm Bull (Tokyo); 2019; 67(10):1061-1071. PubMed ID: 31582626
[TBL] [Abstract][Full Text] [Related]
27. Basic Amino Acids Within the Juxtamembrane Domain of the Epidermal Growth Factor Receptor Regulate Receptor Dimerization and Auto-phosphorylation.
Mohr JD; Wagenknecht-Wiesner A; Holowka DA; Baird BA
Protein J; 2020 Oct; 39(5):476-486. PubMed ID: 33211253
[TBL] [Abstract][Full Text] [Related]
28. Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs.
Mi LZ; Grey MJ; Nishida N; Walz T; Lu C; Springer TA
Biochemistry; 2008 Sep; 47(39):10314-23. PubMed ID: 18771282
[TBL] [Abstract][Full Text] [Related]
29. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
30. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Jura N; Endres NF; Engel K; Deindl S; Das R; Lamers MH; Wemmer DE; Zhang X; Kuriyan J
Cell; 2009 Jun; 137(7):1293-307. PubMed ID: 19563760
[TBL] [Abstract][Full Text] [Related]
31. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract][Full Text] [Related]
32. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
Monsey J; Shen W; Schlesinger P; Bose R
J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
[TBL] [Abstract][Full Text] [Related]
33. Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.
Huang Z; Wang Y; Nayak PS; Dammann CE; Sanchez-Esteban J
J Biol Chem; 2012 May; 287(22):18091-102. PubMed ID: 22493501
[TBL] [Abstract][Full Text] [Related]
34. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.
Komuro A; Nagai M; Navin NE; Sudol M
J Biol Chem; 2003 Aug; 278(35):33334-41. PubMed ID: 12807903
[TBL] [Abstract][Full Text] [Related]
35. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.
Stamos J; Sliwkowski MX; Eigenbrot C
J Biol Chem; 2002 Nov; 277(48):46265-72. PubMed ID: 12196540
[TBL] [Abstract][Full Text] [Related]
36. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
Vidal GA; Naresh A; Marrero L; Jones FE
J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
[TBL] [Abstract][Full Text] [Related]
37. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling.
Carraway KL; Cantley LC
Cell; 1994 Jul; 78(1):5-8. PubMed ID: 8033211
[No Abstract] [Full Text] [Related]
38. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
39. Desensitization by different strategies of epidermal growth factor receptor and ErbB4.
Yamamoto H; Higa-Nakamine S; Noguchi N; Maeda N; Kondo Y; Toku S; Kukita I; Sugahara K
J Pharmacol Sci; 2014; 124(3):287-93. PubMed ID: 24553453
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary analysis of the ErbB receptor and ligand families.
Stein RA; Staros JV
J Mol Evol; 2000 May; 50(5):397-412. PubMed ID: 10824084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
